Ratings by Piper Sandler (David Westenberg)
| Date | Company | Symbol | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/28/2026 | 10X Genomics | TXG | Maintain | Neutral (N/A) |
|
Details | ||
| 9/15/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 9/1/2026 | Tempus AI Inc | TEM | Upgrade | Overweight (Neutral) |
64.04 (85.08) |
32.85% | Details | |
| 8/27/2026 | Waters Corp. | WAT | Upgrade | Overweight (Neutral) |
414.17 (442.94) |
6.95% | Details | |
| 8/26/2026 | Neogen | NEOG | Upgrade | Overweight (Neutral) |
11.60 (13.72) |
18.28% | Details | |
| 8/26/2026 | Trupanion, Inc. | TRUP | Downgrade | Neutral (Overweight) |
31.76 (23.27) |
-26.73% | Details | |
| 8/10/2026 | 10X Genomics | TXG | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2026 | Veracyte, Inc | VCYT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2026 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2026 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2026 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 8/4/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/3/2026 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 7/15/2026 | Veracyte, Inc | VCYT | New Coverage | Overweight (N/A) |
57.48 (45.23) |
-21.31% | Details | |
| 7/1/2026 | 10X Genomics | TXG | Maintain | Neutral (N/A) |
|
Details | ||
| 6/29/2026 | Elanco Animal Health | ELAN | Maintain | Overweight (N/A) |
|
Details | ||
| 6/23/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 6/11/2026 | Waters Corp. | WAT | New Coverage | Neutral (N/A) |
371.15 (414.17) |
11.59% | Details | |
| 6/11/2026 | Twist Bioscience | TWST | New Coverage | Overweight (N/A) |
70.06 (179.60) |
156.35% | Details | |
| 6/11/2026 | Thermo Fisher Scientific | TMO | New Coverage | Neutral (N/A) |
494.07 (678.60) |
37.35% | Details | |
| 6/11/2026 | Bio-Techne Corp. | TECH | New Coverage | Neutral (N/A) |
54.41 (72.51) |
33.27% | Details | |
| 6/11/2026 | Danaher | DHR | New Coverage | Neutral (N/A) |
188.41 (227.33) |
20.66% | Details | |
| 6/11/2026 | Agilent | A | New Coverage | Neutral (N/A) |
135.48 (175.21) |
29.33% | Details | |
| 5/6/2026 | GRAIL, Inc. | GRAL | Maintain | Neutral (N/A) |
|
Details | ||
| 5/5/2026 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 4/21/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/16/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 4/10/2026 | GRAIL, Inc. | GRAL | New Coverage | Neutral (N/A) |
50.78 (132.63) |
161.19% | Details | |
| 4/10/2026 | Caris Life Sciences Inc | CAI | New Coverage | Neutral (N/A) |
19.51 (31.75) |
62.74% | Details | |
| 3/31/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 3/16/2026 | BillionToOne Inc | BLLN | Maintain | Overweight (N/A) |
|
Details | ||
| 3/10/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/24/2026 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 2/24/2026 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/9/2026 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/22/2026 | Zoetis Inc. | ZTS | Downgrade | Neutral (Overweight) |
123.24 (71.43) |
-42.04% | Details | |
| 1/22/2026 | Elanco Animal Health | ELAN | Upgrade | Overweight (Neutral) |
24.16 (22.45) |
-7.08% | Details | |
| 1/13/2026 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 1/12/2026 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 12/15/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 12/10/2025 | BillionToOne Inc | BLLN | Maintain | Overweight (N/A) |
|
Details | ||
| 12/1/2025 | BillionToOne Inc | BLLN | New Coverage | Overweight (N/A) |
127.85 (121.72) |
-4.79% | Details | |
| 11/24/2025 | Exact Sciences | EXAS | Downgrade | Neutral (Overweight) |
100.90 (104.91) |
3.97% | Details | |
| 11/11/2025 | 10X Genomics | TXG | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2025 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2025 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 11/11/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/10/2025 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 11/10/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/27/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/22/2025 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 10/22/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 10/15/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/8/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/3/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2025 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 9/11/2025 | 10X Genomics | TXG | New Coverage | Neutral (N/A) |
13.50 (88.50) |
555.56% | Details | |
| 8/11/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/11/2025 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2025 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/11/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/6/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/4/2025 | GeneDx | WGS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/28/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/9/2025 | GeneDx | WGS | New Coverage | Overweight (N/A) |
85.74 (85.93) |
0.22% | Details | |
| 7/2/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/12/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 5/6/2025 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/6/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 4/22/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 4/14/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 3/19/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 3/6/2025 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2025 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 3/4/2025 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/27/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 2/26/2025 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/20/2025 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/10/2025 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 2/10/2025 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 2/10/2025 | IDEXX Laboratories | IDXX | Maintain | Neutral (N/A) |
|
Details | ||
| 2/3/2025 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 1/21/2025 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 1/3/2025 | Guardant Health | GH | Maintain | Overweight (N/A) |
|
Details | ||
| 11/26/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/12/2024 | Tempus AI Inc | TEM | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/28/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/28/2024 | Laboratory Corporation of America | LH | Maintain | Neutral (N/A) |
|
Details | ||
| 10/1/2024 | Laboratory Corporation of America | LH | New Coverage | Neutral (N/A) |
222.10 (309.57) |
39.38% | Details | |
| 9/27/2024 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 9/20/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 9/12/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/12/2024 | Tempus AI Inc | TEM | New Coverage | Neutral (N/A) |
38.93 (64.04) |
64.5% | Details | |
| 7/29/2024 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 7/19/2024 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 7/1/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/13/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 4/16/2024 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 4/15/2024 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 3/12/2024 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 3/6/2024 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 2/20/2024 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 1/30/2024 | IDEXX Laboratories | IDXX | Downgrade | Neutral (Overweight) |
524.98 (529.06) |
0.78% | Details | |
| 1/18/2024 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 11/13/2023 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/6/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 11/6/2023 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2023 | Invitae Corporation | NVTA | Maintain | Underweight (N/A) |
|
Details | ||
| 10/16/2023 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2023 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/16/2023 | Exact Sciences | EXAS | Maintain | Overweight (N/A) |
|
Details | ||
| 10/16/2023 | Quest Diagnostics | DGX | Maintain | Neutral (N/A) |
|
Details | ||
| 10/16/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 10/10/2023 | Exact Sciences | EXAS | Upgrade | Overweight (Neutral) |
62.70 (100.90) |
60.93% | Details | |
| 9/27/2023 | Guardant Health | GH | Upgrade | Overweight (Neutral) |
26.26 (177.33) |
575.29% | Details | |
| 8/14/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 8/14/2023 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Guardant Health | GH | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Exact Sciences | EXAS | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 8/7/2023 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 6/29/2023 | Quest Diagnostics | DGX | New Coverage | Neutral (N/A) |
142.56 (237.62) |
66.68% | Details | |
| 5/15/2023 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2023 | Zoetis Inc. | ZTS | Maintain | Overweight (N/A) |
|
Details | ||
| 5/8/2023 | Fulgent Genetics | FLGT | Maintain | Neutral (N/A) |
|
Details | ||
| 5/8/2023 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Overweight (N/A) |
|
Details | ||
| 4/11/2023 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 12/21/2022 | Adeptus Biotechnologies Corp. | ADPT | Upgrade | Overweight (Neutral) |
7.26 (28.51) |
292.7% | Details | |
| 12/15/2022 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 12/8/2022 | Fulgent Genetics | FLGT | Downgrade | Neutral (Overweight) |
36.09 (22.36) |
-38.04% | Details | |
| 11/14/2022 | Neogenomics | NEO | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2022 | Fulgent Genetics | FLGT | Maintain | Overweight (N/A) |
|
Details | ||
| 11/14/2022 | Exact Sciences | EXAS | Maintain | Neutral (N/A) |
|
Details | ||
| 11/14/2022 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 11/1/2022 | Guardant Health | GH | Downgrade | Neutral (Overweight) |
47.86 (177.33) |
270.52% | Details | |
| 10/26/2022 | Adeptus Biotechnologies Corp. | ADPT | Maintain | Neutral (N/A) |
|
Details | ||
| 10/10/2022 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 8/17/2022 | Elanco Animal Health | ELAN | Maintain | Neutral (N/A) |
|
Details | ||
| 8/8/2022 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 8/1/2022 | Neogen | NEOG | Maintain | Neutral (N/A) |
|
Details | ||
| 7/26/2022 | IDEXX Laboratories | IDXX | Maintain | Overweight (N/A) |
|
Details | ||
| 7/12/2022 | Neogen | NEOG | New Coverage | Neutral (N/A) |
23.39 (11.60) |
-50.41% | Details | |
| 7/12/2022 | IDEXX Laboratories | IDXX | New Coverage | Overweight (N/A) |
378.45 (529.06) |
39.8% | Details | |
| 7/12/2022 | Zoetis Inc. | ZTS | New Coverage | Overweight (N/A) |
177.98 (71.43) |
-59.87% | Details | |
| 7/12/2022 | Elanco Animal Health | ELAN | New Coverage | Neutral (N/A) |
20.45 (22.45) |
9.78% | Details | |
| 6/3/2022 | Adeptus Biotechnologies Corp. | ADPT | New Coverage | Neutral (N/A) |
7.99 (28.51) |
256.82% | Details | |
| 6/3/2022 | Neogenomics | NEO | New Coverage | Overweight (N/A) |
8.05 (19.29) |
139.63% | Details | |
| 6/3/2022 | Invitae Corporation | NVTA | Maintain | Underweight (N/A) |
|
Details | ||
| 6/3/2022 | Exact Sciences | EXAS | New Coverage | Neutral (N/A) |
48.48 (104.91) |
116.4% | Details | |
| 6/3/2022 | Guardant Health | GH | New Coverage | Overweight (N/A) |
38.65 (177.33) |
358.81% | Details | |
| 3/1/2022 | Fulgent Genetics | FLGT | Maintain | Overweight (N/A) |
|
Details | ||
| 2/4/2022 | Fulgent Genetics | FLGT | New Coverage | Overweight (N/A) |
64.97 (22.36) |
-65.58% | Details |
